Analystreport

Fulcrum Therapeutics (NASDAQ: FULC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report